Prior to joining Collegium, Mr.
Thomson Reuters InCites Collaborative eco-system aids success The open environment supporting collaboration between business and research in Ontario is the envy of innovators and entrepreneurs elsewhere. The Ontario Network of Entrepreneurs is a province-wide network that supports innovation-based entrepreneurs and businesses as they launch and grow globally competitive companies.
The Ontario Centres of Excellence is a link between industry and academia, offering business leaders access to top research talent to help address innovation challenges. The Ontario Health Innovation Council OHIC links experts from the health care, community, home care, medical device, non-profit, mental health, research, academic and business sectors to spur innovation and improve patient outcomes.
The federally funded Centres of Excellence for Commercialization and Research CECR are not-for-profit corporations created by universities, colleges, not-for-profit research organizations, firms, or other interested non-government parties.
Clusters of research expertise are matched with the business community, and each Centre shares knowledge, expertise and resources to bring new pharma products to market faster. Learn more about other incentive programs and services offered by Ontario.
A reputation for excellence Ontario is known for its contributions in key research areas like cancer, neuroscience, stem cells, gene therapy and clinical trials. Major advances in potential treatments for diseases ranging from diabetes to cystic fibrosis to leukemia and early-onset Alzheimer's disease have all originated here thanks to a combination of private and public investment in innovation.
And, Ontario is making site selection even easier with its Investment Ready: Don't just take our word for it — the developments speak for themselves. Major pharmaceutical and life sciences companies have been making sizable investments in their Ontario operations lately.
Triple the size of the current facility, the new Baxter CIVA Pharmacy Service will expand Baxter's ability to meet the needs of Canadian hospitals, clinics and other care facilities for ready-to-administer intravenous IV admixtures, including chemotherapy, high-alert medications and anti-infectives, enabling pharmacists to focus on more direct patient care and clinical activities.
Lower business costs are better for business And what's good for business is good for Ontario.
We know that lower costs mean: Also worth noting for their impact on the bottom line: Canada offers the lowest pharmaceutical production costs in the G7 G7 Country.An industry force In the past few years, the drug product CMO industry has emerged from being a collection of poorly run, mom-and-pop businesses to a real force in the bio/pharmaceutical industry.
Strategic Axis Offer targeted corporate business training, Management courses and professional business programs in UAE.
We address some of the world's most pressing global challenges and continue to develop new solutions. The population is constantly growing and its age is increasing. Glen T. Giovannetti Global Biotechnology Sector Leader Carolyn Buck Luce Global Pharmaceutical Sector Leader Welcome To our clients and friends: Given the extraordinary challenges facing pharmaceutical companies, it is not surprising that recent.
Ethics and the Pharmaceutical Industry [Michael A. Santoro, Thomas M. Gorrie] on initiativeblog.com *FREE* shipping on qualifying offers. Despite the pharmaceutical industry's notable contributions to human progress, including the development of miracle drugs for treating cancer.
SAI Global Introduces the World’s Most Comprehensive With the launch of SAI, recognized Visionary releases next generation of risk management solutions that deliver accelerated time to value Learn more.